Improving
Treatment Access for Skin Cancer Learn More

SURGEONS

Volunteer Your Expertise

PATIENTS

How can iTASC help you?

REFERRING CLINICIANS

Support the Mission

Hope for Every Patient. Help for Every Journey.

At iTASC, we believe no one should face skin cancer alone. We’re here to coordinate micrographic surgical care.

937-345-2350  |  admin@itasc.org

Your health, your hope, your future—it’s why we’re here. iTASC is dedicated to bringing advanced skin cancer treatment to underserved individuals through a compassionate network of volunteer Mohs surgeons and community support. Whether you’re a patient seeking care, a Mohs surgeon ready to make a difference, or a donor looking to create impact, you’re part of a mission that changes lives.

Skin cancer is the most prevalent cancer. Thousands in our underserved population will be diagnosed but do not have access to the quality care that will assure them the best outcomes.

We are looking to recruit support from Mohs surgeons and healthcare providers who can help us in our mission to coordinate treatment access to those who need it.

Most Common Cancer:

Non-melanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the most frequently diagnosed cancer in the United States, with over 3 million cases annually.

Cure Rates with Mohs Surgery:

99%+ cure rate for primary basal cell carcinoma.
97%+ cure rate for primary squamous cell carcinoma.
95%+ cure rate for recurrent basal cell and squamous cell carcinomas.

Why Mohs Surgery?

Mohs surgery is the gold standard treatment for skin cancer, offering the highest cure rates while preserving as much healthy skin as possible.

Fast-Growing Impact:

Squamous cell carcinoma diagnoses are on the rise, increasing by 200% in the past three decades.

Early Detection is Crucial:

When detected early, nearly all skin cancers can be treated successfully, often without requiring extensive surgery.

Underserved Communities at Risk:

Low-income individuals are 40% less likely to access early diagnosis and specialized treatment, leading to worse outcomes.